Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 75 peer-reviewed journal articles Updated
Oncology

Adult T-cell Leukemia/Lymphoma (ATLL) Resource Guide

At a Glance

Adult T-cell leukemia/lymphoma (ATLL) is a rare cancer caused by the HTLV-1 virus. Treatment depends entirely on your specific Shimoyama subtype rather than traditional cancer staging. Because ATLL is rare, patients are strongly advised to seek care at a major comprehensive cancer center.

Being diagnosed with Adult T-cell leukemia/lymphoma (ATLL) can feel like you have been thrust into a completely unknown world. It is a rare diagnosis, and learning that it is connected to a virus (HTLV-1) that may have been in your body for decades can be overwhelming [1].

This resource guide is designed to give you clarity, control, and actionable steps. We will not provide medical advice, but we will equip you with the knowledge you need to sit confidently across from your doctor, understand your lab reports, and participate fully in your care.

How to Use This Guide

We have broken down the journey of understanding and managing ATLL into five key sections. Depending on where you are in your diagnosis, you may want to start with the topic most relevant to you right now:

01

Understanding the Connection Between HTLV-1 and ATLL

Learn about the connection between Adult T-cell leukemia/lymphoma (ATLL) and the HTLV-1 virus. Understand transmission, latency, and treatment options.

02

Symptoms, Biology, and Your Diagnosis

Learn about Adult T-cell leukemia/lymphoma (ATLL) symptoms, HTLV-1 biology, and how to read your pathology report for markers like flower cells and CD25+.

03

Subtypes and the Shimoyama Classification

Learn about the four Adult T-cell leukemia/lymphoma (ATLL) subtypes. Understand the Shimoyama classification, key lab markers, and what they mean for treatment.

04

Standard Treatment Strategies

Explore standard ATLL treatment strategies based on your Shimoyama subtype. Learn about watchful waiting, antivirals, chemotherapy, and stem cell transplants.

05

Outlook and Living with ATLL

Learn about living with Adult T-cell leukemia/lymphoma (ATLL). Understand prognosis models, watchful waiting, molecular markers, and monitoring your health.

Your First Step: Breathe and Organize

Because ATLL is rare in many parts of the world, it is highly recommended to seek care at a major academic or comprehensive cancer center [2]. As you prepare for your upcoming appointments, gather all your pathology reports, blood test results (especially your LDH and calcium levels), and any imaging scans. Having these organized will help your new care team get up to speed immediately.

Common questions in this guide

What causes Adult T-cell leukemia/lymphoma (ATLL)?
ATLL is caused by the human T-cell lymphotropic virus type 1 (HTLV-1). This is a virus that can remain dormant in the body for decades before causing the disease.
Should my family members be tested for HTLV-1?
Because ATLL is linked to the HTLV-1 virus, it is often recommended to discuss screening close family members with your doctor to understand their potential risk and take necessary precautions.
How is ATLL staged?
Unlike many other cancers, ATLL is not staged using a traditional numbered staging system. Instead, doctors categorize it into four distinct subtypes using the Shimoyama classification, which directly guides your treatment plan.
What kind of doctor should treat my ATLL?
Because ATLL is a rare condition, it is highly recommended to seek care at a major academic or comprehensive cancer center. Look for hematologists and oncologists who have specific experience treating this complex disease.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should my close family members be screened for HTLV-1?
  2. 2.How many cases of ATLL do you see in a typical year at this center?
  3. 3.Who will be the primary point of contact on my care team for urgent questions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (2)
  1. 1

    Peripheral lymphocytosis presenting as EBV/HTLV-1 co-infection adult T-cell leukemia.

    Kasinathan G, Sathar J

    Hematology, transfusion and cell therapy 2022; (44(2)):279-283 doi:10.1016/j.htct.2020.09.146.

    PMID: 33281112
  2. 2

    Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.

    Shah UA, Shah N, Qiao B, et al.

    Cancer 2020; (126(3)):567-574 doi:10.1002/cncr.32556.

    PMID: 31769871

This guide provides a general overview of Adult T-cell leukemia/lymphoma (ATLL) for educational purposes. Always consult your hematologist-oncologist at a comprehensive cancer center for personalized medical advice, diagnosis, and treatment planning.

Get notified when new evidence is published on Adult T-cell leukemia/lymphoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.